论文部分内容阅读
目的评价改良手术联合激光治疗新生血管性青光眼合并玻璃体积血的疗效与安全性。方法新生血管性青光眼合并玻璃体积血21例,22眼。根据分期分别采用改良玻璃体切割术、改良小梁切除术联合激光治疗;改良玻璃体切割术联合激光等两种方法治疗。治疗后随访3～36个月。结果显效10眼(45.5%),有效8眼(36.4%),无效4眼(18.2%)。术前平均眼压(32.24±8.32)mmHg,术后平均眼压(27.28±6.31)mmHg,两者比较差别有统计学意义(P<0.05)。玻璃体积血完全消退12眼(54.5%),视力提高7眼(31.8%),4眼(18.2%)眼压失控行睫状体冷冻治疗。结论改良手术联合激光治疗新生血管性青光眼合并玻璃体积血在一定程度上能阻止疾病发展,保留一定视力,较为安全。
Objective To evaluate the efficacy and safety of modified surgery and laser in the treatment of neovascular glaucoma combined with vitreous hemorrhage. Methods Neovascular glaucoma with vitreous hemorrhage in 21 cases, 22 eyes. According to staging using modified vitrectomy, modified trabeculectomy combined with laser treatment; modified vitrectomy combined with laser and other two methods of treatment. Follow-up 3 to 36 months after treatment. The results were markedly effective in 10 eyes (45.5%), effective in 8 eyes (36.4%), ineffective in 4 eyes (18.2%). The average preoperative intraocular pressure (32.24 ± 8.32) mmHg, postoperative average intraocular pressure (27.28 ± 6.31) mmHg, the difference was statistically significant (P <0.05). Vitreous hemorrhage completely disappeared in 12 eyes (54.5%), visual acuity improved in 7 eyes (31.8%), and in 4 eyes (18.2%) intraocular pressure uncontrolled ciliary body cryotherapy. Conclusion Modified surgery combined with laser treatment of neovascular glaucoma combined with vitreous hemorrhage can prevent the disease to some extent, retain a certain vision, safer.